Nicolas Kurgansky

Long‐term follow‐up of PET / CT ‐adapted therapy after three cycles of ABVD for all stages of classic Hodgkin lymphoma: Results of the GATLA LH ‐05 trial

Summary The Grupo Argentino de Tratamiento de la Leucemia Aguda (GATLA) LH‐05 trial evaluated positron emission tomography‐computed tomography (PET‐CT)‐guided ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) in patients with stage I–IV classic Hodgkin lymphoma (cHL). A...